Helius Medical Technologies, Inc. provided unaudited revenue guidance for the fourth quarter of 2021. For the quarter, the company expects revenues to be between $250,000 and $260,000.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.975 USD | +1.29% |
|
-3.47% | -87.87% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.87% | 2.89M | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+0.80% | 63.2B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Provides Unaudited Revenue Guidance for the Fourth Quarter of 2021